Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.
暂无分享,去创建一个
A. Zietman | M. Roach | M. Graefen | G. Gandaglia | A. Briganti | R. Karnes | N. Clarke | P. Ost | R. Karnes
[1] F. Montorsi,et al. Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series. , 2017, European urology.
[2] T. Schlomm,et al. Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy , 2017, BJU international.
[3] H. G. van der Poel,et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2017, European urology.
[4] F. Montorsi,et al. Early Postoperative Radiotherapy is Associated with Worse Functional Outcomes in Patients with Prostate Cancer , 2017, The Journal of urology.
[5] David Gillatt,et al. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. , 2017, The New England journal of medicine.
[6] A. Wong,et al. Adjuvant radiation with hormonal therapy is associated with improved survival in men with pathologically involved lymph nodes after radical surgery for prostate cancer. , 2016, Urologic oncology.
[7] H. G. van der Poel,et al. The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer Patients. , 2016, European urology.
[8] Adam P Dicker,et al. Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis. , 2016, The Lancet. Oncology.
[9] Shree Agrawal,et al. Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] S. Freedland,et al. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy. , 2016, European urology.
[11] F. Montorsi,et al. Predicting the 5-Year Risk of Biochemical Relapse After Postprostatectomy Radiation Therapy in ≥PT2, pN0 Patients With a Comprehensive Tumor Control Probability Model. , 2016, International journal of radiation oncology, biology, physics.
[12] J. Yaxley,et al. The use of 68 Ga‐PSMA PET CT in men with biochemical recurrence after definitive treatment of acinar prostate cancer , 2016, BJU international.
[13] W. Harmsen,et al. Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] S. Fisher,et al. Evidence of prostate cancer "reverse stage migration" toward more advanced disease at diagnosis: Data from the Pennsylvania Cancer Registry. , 2016, Urologic oncology.
[15] B. Dubray,et al. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. , 2016, The Lancet. Oncology.
[16] R. Orecchia,et al. No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy. , 2016, The British journal of radiology.
[17] M. Borre,et al. Salvage radiation therapy following radical prostatectomy. A national Danish study , 2016, Acta oncologica.
[18] B. Trock,et al. Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk , 2016, Prostate Cancer and Prostatic Disease.
[19] P. Stricker,et al. 68Ga‐PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment , 2016, BJU international.
[20] F. Montorsi,et al. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy. , 2016, European urology.
[21] Sender Herschorn,et al. Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis , 2016, British Medical Journal.
[22] F. Montorsi,et al. Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy , 2016, Prostate Cancer and Prostatic Diseases.
[23] D. Grignon,et al. NRG Oncology/RTOG 9601, a phase III trial in prostate cancer patients: Anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA. , 2016 .
[24] H. Sung,et al. Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy , 2016, International journal of urology : official journal of the Japanese Urological Association.
[25] P. Wust,et al. Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] F. Montorsi,et al. Patterns of Clinical Recurrence of Node-positive Prostate Cancer and Impact on Long-term Survival. , 2015, European urology.
[27] A. Jemal,et al. Declining Use of Radiotherapy for Adverse Features After Radical Prostatectomy: Results From the National Cancer Data Base. , 2015, European urology.
[28] F. Montorsi,et al. The Role of Radiotherapy After Radical Prostatectomy in Patients with Prostate Cancer , 2015, Current Oncology Reports.
[29] S. Byun,et al. Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy , 2015, Strahlentherapie und Onkologie.
[30] H. Rexer,et al. Adjuvante Strahlentherapie beim lymphknotenpositiven Prostatakarzinom mit geringer Tumorlast nach radikaler Prostatektomie , 2015, Der Urologe.
[31] B. Kavanagh,et al. External Validation of the Benefit of Adjuvant Radiotherapy for Pathologic N1M0 Prostate Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] F. Montorsi,et al. Penile rehabilitation after radical prostatectomy: does it work? , 2015, Translational andrology and urology.
[33] T. Hyslop,et al. Assessing adverse events of postprostatectomy radiation therapy for prostate cancer: evaluation of outcomes in the Regione Emilia-Romagna, Italy. , 2015, International journal of radiation oncology, biology, physics.
[34] F. Feng,et al. Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] J. Patard,et al. Early PSA level decline is an independent predictor of biochemical and clinical control for salvage postprostatectomy radiotherapy. , 2015, Urologic oncology.
[36] T. Joensuu,et al. Adjuvant Radiotherapy for Lymph‐node Positive Prostate Cancer , 2015, BJU international.
[37] T. Hyslop,et al. Radiation Therapy after Radical Prostatectomy for Prostate Cancer: Evaluation of Complications and Influence of Radiation Timing on Outcomes in a Large, Population-Based Cohort , 2015, PloS one.
[38] P. Kantoff,et al. Role of androgen deprivation therapy in early salvage radiation among patients with prostate-specific antigen level of 0.5 or less. , 2015, Clinical genitourinary cancer.
[39] T. Hyslop,et al. Adjuvant Versus Salvage Radiation Therapy for Prostate Cancer Patients With Adverse Pathologic Features: Comparative Analysis of Long-term Outcomes , 2015, American journal of clinical oncology.
[40] C. Rübe,et al. Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial. , 2015, International journal of radiation oncology, biology, physics.
[41] F. Montorsi,et al. Early radiotherapy after radical prostatectomy improves cancer‐specific survival only in patients with highly aggressive prostate cancer: Validation of recently released criteria , 2015, International journal of urology : official journal of the Japanese Urological Association.
[42] Cesare Cozzarini,et al. Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] F. Montorsi,et al. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients. , 2014, European urology.
[44] L. Salomon,et al. Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study , 2014, World Journal of Urology.
[45] F. Montorsi,et al. Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy. , 2014, European urology.
[46] F. Montorsi,et al. The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[47] C. Catton,et al. Long-term complications in men who have early or late radiotherapy after radical prostatectomy. , 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.
[48] N. Willich,et al. Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial. , 2014, European urology.
[49] S. Byun,et al. Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes , 2014, PloS one.
[50] F. Feng,et al. Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy , 2014, International journal of radiation oncology, biology, physics.
[51] L. Ceriani,et al. Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET/CT in restaging prostate cancer patients: a meta-analysis , 2014, Clinical chemistry and laboratory medicine.
[52] U. Capitanio,et al. Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. , 2014, European urology.
[53] T. Wiegel,et al. Salvage radiotherapy in patients with prostate cancer and biochemical relapse after radical prostatectomy , 2014, Strahlentherapie und Onkologie.
[54] N. Lumen,et al. Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[55] H. G. van der Poel,et al. Salvage radiotherapy after robot-assisted laparoscopic radical prostatectomy. , 2013, Urology.
[56] R. Mehra,et al. Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer–specific death in patients receiving salvage radiation therapy following radical prostatectomy , 2013, Cancer.
[57] S. Goldenberg,et al. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. , 2013, The Journal of urology.
[58] T. Wiegel,et al. Phase 3 study of adjuvant radiotherapy versus wait and see in pT3 prostate cancer: impact of pathology review on analysis. , 2013, European urology.
[59] U. Capitanio,et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. , 2013, European urology.
[60] S. Lipsitz,et al. Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy , 2013, BJU international.
[61] C. Ménard,et al. Treatment-related toxicity and symptom-related bother following postoperative radiotherapy for prostate cancer. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.
[62] L. Collette,et al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) , 2012, The Lancet.
[63] B. Trock,et al. The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary. , 2012, The Journal of urology.
[64] J. Ciezki,et al. Twenty-year Competing Risk Analysis of Secondary Malignancies After External Beam Radiation for Postoperative Treatment of Prostate Cancer Patients From the SEER Database , 2012 .
[65] P. Scardino,et al. Long-term outcomes after high-dose postprostatectomy salvage radiation treatment. , 2012, International journal of radiation oncology, biology, physics.
[66] C. King. The timing of salvage radiotherapy after radical prostatectomy: a systematic review. , 2012, International journal of radiation oncology, biology, physics.
[67] T. Guzzo,et al. Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA. , 2012, International journal of radiation oncology, biology, physics.
[68] F. Montorsi,et al. High-dose adjuvant radiotherapy after radical prostatectomy with or without androgen deprivation therapy. , 2012, International journal of radiation oncology, biology, physics.
[69] T. Wiegel,et al. Salvage radiotherapy after prostatectomy - what is the best time to treat? , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[70] B. Guillonneau,et al. A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. , 2012, European urology.
[71] A. Dicker,et al. Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling. , 2012, European journal of cancer.
[72] P. Span,et al. High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy. , 2012, International journal of radiation oncology, biology, physics.
[73] A. Zietman,et al. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. , 2012, European urology.
[74] H. Sandler,et al. Concurrent androgen deprivation therapy during salvage prostate radiotherapy improves treatment outcomes in high-risk patients. , 2012, International journal of radiation oncology, biology, physics.
[75] U. Capitanio,et al. Preoperative erectile function represents a significant predictor of postoperative urinary continence recovery in patients treated with bilateral nerve sparing radical prostatectomy. , 2012, The Journal of urology.
[76] B. Hickey,et al. Adjuvant radiotherapy following radical prostatectomy for prostate cancer. , 2011, The Cochrane database of systematic reviews.
[77] P. Scardino,et al. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy. , 2011, European urology.
[78] K. Jingu,et al. Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml , 2011, Radiation oncology.
[79] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[80] N. Lumen,et al. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results. , 2011, European urology.
[81] A. D'Amico,et al. Salvage radiation in men after prostate‐specific antigen failure and the risk of death , 2011, Cancer.
[82] V. Fonteyne,et al. A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer. , 2011, International journal of radiation oncology, biology, physics.
[83] T. Wiegel,et al. Dose Escalation for Patients with Decreasing PSA during Radiotherapy for Elevated PSA after Radical Prostatectomy Improves Biochemical Progression-Free Survival , 2011, Strahlentherapie und Onkologie.
[84] M. Ritter,et al. Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence , 2011, Cancer.
[85] U. Capitanio,et al. Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. , 2011, European urology.
[86] B. Trock,et al. Causes of death after radical prostatectomy at a large tertiary center. , 2011, The Journal of urology.
[87] L. Kiemeney,et al. Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[88] C. Perneel,et al. A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[89] A. D'Amico,et al. Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death , 2010, BJU international.
[90] Anurag K. Singh,et al. Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis. , 2010, International journal of radiation oncology, biology, physics.
[91] T. Wiegel,et al. Salvage Radiotherapy in Patients with Prostate Cancer and Biochemical Relapse after Radical Prostatectomy: Long-term Follow-up of a Single Center Survey , 2010 .
[92] M. Heckman,et al. Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis. , 2010, International journal of radiation oncology, biology, physics.
[93] F. Montorsi,et al. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients. , 2009, International journal of radiation oncology, biology, physics.
[94] C. Fiorino,et al. IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[95] M. Terris,et al. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database , 2009, BJU international.
[96] N. Lumen,et al. Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients. , 2009, European urology.
[97] I. Reis,et al. Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data. , 2009, Urology.
[98] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[99] R. Orecchia,et al. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy. , 2009, International journal of radiation oncology, biology, physics.
[100] A. Kibel. Identification of Patients With Prostate Cancer Who Benefit From Immediate Postoperative Radiotherapy: EORTC 22911 , 2008 .
[101] Misop Han,et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. , 2008, JAMA.
[102] F. Montorsi,et al. TWO POSITIVE NODES REPRESENT A SIGNIFICANT CUT-OFF VALUE FOR CANCER SPECIFIC SURVIVAL IN PATIENTS WITH NODE POSITIVE PROSTATE CANCER. A NEW PROPOSAL BASED ON A TWO INSTITUTION EXPERIENCE ON 784 CONSECUTIVE N+ PATIENTS , 2008 .
[103] S. Hancock,et al. Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients. , 2007, International journal of radiation oncology, biology, physics.
[104] Richard K Valicenti,et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[105] M. Parmar,et al. RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery). , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).
[106] E. Messing,et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. , 2006, JAMA.
[107] Daniel W. Miller,et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. , 2005, JAMA.
[108] M. Piérart,et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) , 2005, The Lancet.
[109] Steve P Lee,et al. Effect of pelvic lymph node irradiation in salvage therapy for patients with prostate cancer with a biochemical relapse following radical prostatectomy. , 2004, Clinical prostate cancer.
[110] J. Moul,et al. Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy. , 2003, Urology.
[111] M. Menon,et al. Population‐Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients , 2017, The Prostate.
[112] A. Vickers,et al. Adverse Pathologic Features at Radical Prostatectomy: Effect of Preoperative Risk on Oncologic Outcomes. , 2016, European urology.
[113] H. Sandler,et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. , 2016, European urology.
[114] P. Scardino,et al. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. , 2014, European urology.
[115] M. Anscher,et al. Elective irradiation of pelvic lymph nodes during postprostatectomy salvage radiotherapy , 2013, Cancer.
[116] F. Montorsi,et al. Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients. , 2012, International journal of radiation oncology, biology, physics.
[117] L. Livi,et al. Adjuvant and salvage radiotherapy after prostatectomy: outcome analysis of 307 patients with prostate cancer , 2012, Journal of Cancer Research and Clinical Oncology.
[118] C. Lawton. Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial , 2010 .
[119] I. Thompson,et al. Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[120] A. Kibel. Predominant Treatment Failure in Postprostatectomy Patients Is Local: Analysis of Patterns of Treatment Failure in SWOG 8794 , 2008 .
[121] R. Ackermann. Postoperative Radiotherapy After Radical Prostatectomy: A Randomised Controlled Trial (EORTC trial 22911) , 2006 .